Evidence map›Paper›PMID 29859366›Full record

ArticleActa biomaterialia2018

Strontium-releasing fluorapatite glass-ceramic scaffolds: Structural characterization and in vivo performance.

Isabelle Denry, Ourania-Menti Goudouri, Douglas C Fredericks, Adil Akkouch, Michael R Acevedo, Julie A Holloway

Open access · hybridAbstract read
In one paragraph

Article in Acta biomaterialia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Review
  3. Harnessing strontium in regenerative dentistry: progress and perspectives.Frontiers in bioengineering and biotechnology · 2025
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Isabelle DenryIowa Institute for Oral Health Research, University of Iowa College of Dentistry, Iowa City, Iowa, United States; Department of Prosthodontics, University of Iowa College of Dentistry, Iowa City, Iowa, United States. Electronic address: Isabelle-Denry@uiowa.edu.
Ourania-Menti GoudouriIowa Institute for Oral Health Research, University of Iowa College of Dentistry, Iowa City, Iowa, United States.
Douglas C FredericksIowa Spine Research Laboratory, Department of Orthopaedic Surgery and Rehabilitation, University of Iowa Carver College of Medicine, Iowa City, Iowa, United States.
Adil AkkouchIowa Institute for Oral Health Research, University of Iowa College of Dentistry, Iowa City, Iowa, United States.
Michael R AcevedoDepartment of Radiology, University of Iowa Roy J. and Lucille A. Carver College of Medicine, Iowa City, Iowa, United States.
Julie A HollowayDepartment of Prosthodontics, University of Iowa College of Dentistry, Iowa City, Iowa, United States.
University of Iowa · US

Funding

Ceramic scaffolds with engineered topography and chemistryR01DE019972 · NIDCR · UNIVERSITY OF IOWA · PI DENRY, ISABELLE L · 2010 to 2014
$1.8M
Nodestruction Multi-Scale Micro-CT Imaging SystemS10OD018503 · OD · UNIVERSITY OF IOWA · PI SIEREN, JESSICA C · 2015 to 2015
$1.1M
NIDCR NIH HHS R01 DE019972NIH HHS S10 OD018503
6 · The paper itself

Abstract

There is increasing interest in biodegradable ceramic scaffolds for bone tissue engineering capable of in situ delivery of ionic species favoring bone formation. Strontium has been shown to be osteogenic, but strontium-containing drugs such as strontium ranelate, used in Europe for the treatment of osteoporosis, are now restricted due to clinical evidence of systemic effects. By doping fluorapatite-based glasses with strontium, we developed ceramic scaffolds with fully interconnected macroporosity and cell size similar to that of cancellous bone, that are also capable of releasing strontium. The crystallization behavior, investigated by XRD and SEM, revealed the formation of akermanite and fluorapatite at the surface of strontium-free glass-ceramic scaffolds, and strontium-substituted fluorapatite at the surface of the strontium-doped scaffolds. At 8 weeks after implantation in a rat calvarial critical size defect, scaffolds doped with the highest amount of strontium led to the highest mineral apposition rate. A significantly higher amount of newly-formed bone was found with the strontium-free glass-ceramic scaffold, and possibly linked to the presence of akermanite at the scaffold surface. We demonstrate by energy dispersive XRF analyses of skull sections that strontium was present in newly formed bone with the strontium-doped scaffolds, while a significant amount of fluorine was incorporated in newly formed bone, regardless of composition or crystallization state. STATEMENT OF SIGNIFICANCE: The present work demonstrates the in vivo action of strontium-containing glass-ceramic scaffolds. These bone graft substitutes are targeted at non load-bearing bone defects. Results show that strontium is successfully incorporated in newly formed bone. This is associated with a significantly higher Mineral Apposition Rate. The benefits of in situ release of strontium are demonstrated. The broader scientific impact of this works builds on the concept of resorbable ceramic scaffolds as reservoirs of ionic species capable of enhancing bone regeneration.

Indexed as

ApatitesBone SubstitutesCeramicsSkullStrontiumAnimalsOsteogenesisRatsTissue ScaffoldsApatitesBone SubstitutesfluorapatiteGlass ceramicsStrontiumAkermaniteFluorapatiteOsteogenesisScaffoldStrontium

Identifiers

PMID29859366
PMCPMC6119524
OpenAlexW2805424875

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.